AG
AGENDIA NV
Grant-FundedCORDISMolecularly guided trials with specific treatment strategies in patients with advanced newly molecular defined subtypes of colorectal cancer (MoTriColor)
Biotech · SaaS
AGENDIA NV is a private SME recorded in CORDIS in Netherlands, with participation in 4 EU research and innovation projects. Its recorded projects include “Molecularly guided trials with specific treatment strategies in patients with advanced newly molecular defined subtypes of colorectal cancer (MoTriColor)”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
EU Grants€6,230,457
All-time revenue—
MRRPrivate••••••
Founder—
Founded—
🇳🇱Netherlands
RevenuePrivate
Revenue data is privateThis company has chosen not to share revenue metrics
Startup insights
Value proposition
AGENDIA NV is a private SME recorded in CORDIS in Netherlands, with participation in 4 EU research and innovation projects. Its recorded projects include “Molecularly guided trials with specific treatment strategies in patients with advanced newly molecular defined subtypes of colorectal cancer (MoTriColor)”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
BiotechSaaS
Tags:BiotechSaaS
Company Info
AGENDIA NV Info
Funding
EU Grants€6,230,457